Vitrex Medical Group has acquired Herniamesh
April 2026 — Vitrex Medical Group (VMG) has acquired Herniamesh, an Italy-based manufacturer of specialized medical materials for surgical applications. The acquisition strengthens VMG’s surgical division by expanding its portfolio of surgical products for hernia repair, gynecological meshes, incontinence treatment and biological materials.
VMG is a European manufacturer of disposable medical devices with a portfolio focused on diabetes care, invasive drug delivery systems and surgical products, including lancets, syringes, needles, cannulas, surgical sutures and capillary tubes.
Herniamesh is an Italian manufacturer of medical devices for inguinal and abdominal hernia repair, female urinary incontinence and pelvic floor disorders. The company serves customers worldwide through an established distribution network.
Our role in the transaction
Oaklins’ team in Slovakia acted as the buy-side advisor to VMG in this acquisition. The team supported the client throughout the transaction process, including target analysis, valuation, transaction structuring, coordination of due diligence and assistance with negotiations and documentation.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Learn more